Exelixis
EXEL
#1324
Rank
A$25.19 B
Marketcap
A$103.25
Share price
-0.43%
Change (1 day)
56.85%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company